Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Interest Expenses (2018 - 2025)

Historic Interest Expenses for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $3.5 million.

  • TransMedics' Interest Expenses fell 348.35% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year decrease of 307.42%. This contributed to the annual value of $14.4 million for FY2024, which is 3352.79% up from last year.
  • As of Q3 2025, TransMedics' Interest Expenses stood at $3.5 million, which was down 348.35% from $3.5 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Interest Expenses peaked at $3.6 million during Q2 2024, and registered a low of $787000.0 during Q3 2022.
  • Its 5-year average for Interest Expenses is $2.3 million, with a median of $2.5 million in 2023.
  • As far as peak fluctuations go, TransMedics' Interest Expenses plummeted by 1961.18% in 2022, and later surged by 35616.26% in 2023.
  • Quarter analysis of 5 years shows TransMedics' Interest Expenses stood at $978000.0 in 2021, then rose by 2.97% to $1.0 million in 2022, then skyrocketed by 257.99% to $3.6 million in 2023, then dropped by 0.94% to $3.6 million in 2024, then decreased by 2.24% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $3.5 million for Q2 2025, and $3.5 million during Q1 2025.